B‐1 cells produce insulin and abrogate experimental streptozotocin‐induced diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|45|5|1452-1461

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.5, 2015-05, pp. : 1452-1461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Dysfunction in Streptozotocin-Induced Experimental Diabetes Strictly Depends on Insulin Deficiency

By  

Journal of Vascular Research, Vol. 48, Iss. 4, 2011-01 ,pp. : 275-284

Karger

Access to resources Recommend Favorite

Interleukin‐17A deficiency ameliorates streptozotocin‐induced diabetes

By  

IMMUNOLOGY, Vol. 146, Iss. 2, 2015-10 ,pp. : 339-346

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐17A deficiency ameliorates streptozotocin‐induced diabetes

By  

IMMUNOLOGY, Vol. 19-2805, Iss. 2, 2015-10 ,pp. : 339-346

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protective Effect of the Nuclear Factor Kappa B Inhibitor Pyrrolidine Dithiocarbamate in Lung Injury in Rats with Streptozotocin-Induced Diabetes

By  

Respiration, Vol. 79, Iss. 5, 2009-12 ,pp. : 402-410

Karger

Access to resources Recommend Favorite

Brugia malayi soluble and excretory‐secretory proteins attenuate development of streptozotocin‐induced type 1 diabetes in mice

By  

PARASITE IMMUNOLOGY (ELECTRONIC), Vol. 37, Iss. 12, 2015-12 ,pp. : 624-634

John Wiley & Sons Inc

Access to resources Recommend Favorite